MedTrace Logo

Exploratory Study: COVID-19 and Pregnancy

NCT04647994 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-06-09

No results posted yet for this study

Summary

The SARS-CoV-2 infection may behave differently in pregnant and postpartum women in the short and long term. Several risk factors or medication use can interfere on disease' evolution and vertical transmission. Thus, due the current pandemic and the scarcity of scientific studies involving pregnant women with covid-19 or positive serology, combined with the need to elucidate the behavior of this viral infection in pregnant women in our population, this study aims to evaluate the clinical and laboratory evolution, transplacental passage, gestational and neonatal outcomes in pregnancies with positive SARS-CoV-2.

Conditions

  • Pregnant Women
  • Covid19

Interventions

DIAGNOSTIC_TEST

SARS-CoV-2 serology

Serology test of SARS-CoV-2 for pregnant women

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Rossana P Francisco, PhD · Faculdade de Medicina da Universidade de São Paulo - FMUSP

Eligibility

Min Age
17 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-11
Primary Completion
2022-06-01
Completion
2022-06-13

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04647994 on ClinicalTrials.gov